Kyntra Bio, Inc. (KYNB) stock
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.95−0.09 (-4.41%)
Close on Nov 18, 2026Market cap $7.90MP/E 0.0Yield –
Kyntra Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kyntra Bio's market cap was $14.90M on Nov 11, 2026, against $35.60M a year earlier. Over the last 5 years it ranged from $14.90M to $2.22B, with a median of $54.32M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $14.90M | -58.0% |
| 2025 | Dec 31, 2025 | $35.52M | -33.4% |
| 2024 | Dec 31, 2024 | $53.36M | -38.8% |
| 2023 | Dec 29, 2023 | $87.16M | -94.2% |
| 2022 | Dec 30, 2022 | $1.50B | +15.1% |
| 2021 | Dec 31, 2021 | $1.31B | -61.2% |
| 2020 | Dec 31, 2020 | $3.37B | -9.9% |
| 2019 | Dec 31, 2019 | $3.74B | -4.7% |
| 2018 | Dec 31, 2018 | $3.93B | +1.3% |
| 2017 | Dec 29, 2017 | $3.88B | +187.3% |
| 2016 | Dec 30, 2016 | $1.35B | -27.7% |
| 2015 | Dec 31, 2015 | $1.87B | +417.6% |
| 2014 | Dec 31, 2014 | $360.51M | – |
See a number that looks wrong?